Patient Safety and Adverse Drug Events in Medication Practice
A special issue of Pharmacy (ISSN 2226-4787).
Deadline for manuscript submissions: closed (31 July 2018) | Viewed by 32379
Interests: medicines management; patient safety; nursing care
Special Issues, Collections and Topics in MDPI journals
Adverse drug events (ADEs) and medication-related hospitalisations are of main concern across the world. It has been reported that medication errors and healthcare-related ADEs are responsible for a considerable percent of treatment follow ups and hospitalisations in healthcare settings. Therefore, there is a need to reduce ADEs and also the provision of safe healthcare services, by healthcare providers, using preventive and pro-active interventions, including optimal prescribing, dispensing, administration and monitoring of medicines, and reporting ADEs.
The development of strategies to identify preventable ADEs and incorporate appropriate strategies, by physicians, nurses, and pharmacists in routine care, require knowledge development and evident-based practice. Therefore, this Special Issue, “Patient Safety and Adverse Drug Events in Medication Practice”, aims to open the discussion on medicine management, with a focus on ADEs as important components of patient safety. In this Special Issue, research articles, theoretical and methodological reviews on ADEs are welcomed. Additionally, practical experiences and reflections on the application of advanced technologies and new methods of medicine management for ADEs are encouraged.
Dr. Mojtaba Vaismoradi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Adverse Drug Events
- Drug-Related Side Effects and Adverse Reactions
- Medication error
- Medicines’ management
- Patient safety
- Pro re nata (PRN)